Guardian Pharmacy Services, Inc. (GRDN)
NYSE: GRDN · Real-Time Price · USD
49.52
+0.14 (0.28%)
Nov 13, 2026, 4:00 PM EST - Market closed

GRDN Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,4571,4491,2281,046908.91792.07
Revenue Growth
4.85%17.93%17.42%15.10%14.75%7.63%
Gross Profit
327.08292.72244.37208.31185.87161.27
Operating Income
94.380.29-60.1564.451.9930.15
Net Income
74.7749.22-110.05-35.4216.31
Earnings Per Share
1.170.78-1.77---
EPS Growth
326.17%-----

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
119.6665.624.660.750.6115.01
Total Debt
40.644.7237.3369.1562.9855.04
Net Cash (Debt)
79.0620.9-32.67-68.4-62.38-40.03
Net Cash Growth
------
Net Cash Per Share
1.240.33-0.53---

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
114.06100.2657.9670.8248.5258.5
Capital Expenditures
-17.89-19.55-16.37-14.56-16.77-9.28
Free Cash Flow
96.1780.7141.5956.2631.7549.22
Free Cash Flow Growth
41.06%94.05%-26.08%77.20%-35.48%11.17%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
22.45%20.21%19.89%19.91%20.45%20.36%
Operating Margin
6.47%5.54%-4.90%6.16%5.72%3.81%
Pretax Margin
7.22%5.07%-5.41%3.61%5.46%3.58%
Profit Margin
5.13%3.40%-8.96%-3.90%2.06%
FCF Margin
6.60%5.57%3.39%5.38%3.49%6.21%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
42.2438.71----
Forward PE
33.7329.0024.31---
P/FCF Ratio
32.6223.6130.83---
PS Ratio
2.151.321.04---